An open non randomized clinical trial to evaluate the effectiveness of Tachyspermum ammi powder - Oma chooranam in the management of moolam (Internal hemorrhoids) among out-patients attending Ayothidoss Pandithar Hospital, National Institute of Siddha, Chennai

Background: Hemorrhoid disease is the fourth leading out-patient gastrointestinal diagnosis in world wide. It arises from congestion of the internal and/or external venous plexuses around the anal canal. Aim: The aim of this study was to evaluate the therapeutic effectiveness of siddha herbal formulation Oma chooranam in the management of moolam (Internal Hemorrhoids) patients through proctoscopy and Hemorrhoid Symptom Score (HSS) before and after treatment. Materials and Methods: This study was an open non randomized clinical trial and it was was conducted after getting Institutional Ethical Committee clearance. Patients (N=10) diagnosed with moolam (internal haemorrhoids) using proctscopy results, were enrolled in the study over a period of 6 months (from February 2022 to August 2022). Each patient received 3grams of Oma chooranam mixed in warm water twice a day, for 24 days and patients were followed up for 2 months. The main outcome measure of this study was efficacy assessment, which was measured by using Haemorrhoid Symptom Severity scores(HSS Score) on Day-0 (baseline) and 25th day. Result and conclusion: Biostatistical p value using Wilcoxon signed rank test of HSS scores before and after treatment is less than 0.05. There was significant reduction in clinical symptoms having p value is 0.01 and hence it is clear that “Omachooranam” for the management of hemorrhoid the treatment was effective and significant. Keywords: Oma chooranam,Internal hemorrhoids,Tachyspermum ammi powder, Siddha, Bleeding piles,moolam.